ANG Lifesciences India Approves Q2 Results and Appoints Additional Independent Director
ANG Lifesciences India Ltd 路 Change in Management 路 15 Nov 2026, 3:04 am
ANG Lifesciences India Approves Q2 Results and Appoints Additional Independent Director ANG Lifesciences India Limited's Board approved the unaudited standalone and consolidated financial results along with the limited review report for the quarter and half-year ended 30th Sep'26. Additionally, the Board approved the appointment of Mrs. Preeti Sarin as an Additional Independent Director for a five-year term effective 14th Nov'26 to 13th Nov'31, subject to shareholder approval. Sarin holds a BBA degree with over a decade of administrative and operational experience and is unrelated to any existing board directors.
Original exchange filing (PDF)
More announcements from ANG Lifesciences India Ltd
- Financial Results for the quarter and half year ended 30.09.2026. 路 15 Nov 2026
- Approval of Unaudited Financial Results for the quarter and half year ended 30-09-2026. 路 15 Nov 2026
- ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Unaudited Financial .... 路 14 Nov 2026
- Scrutinizer''s Report for AGM along with Voting Results 路 01 Oct 2026
- Re-appointment of Ms. Chetna as the Independent Director of the company. 路 30 Sept 2026
- Proceedings of 20th Annual General Meeting are enclosed herewith. 路 30 Sept 2026
- Pursuant to Regulations 30 and 34 of the SEBI (LODR) Regulations, 2015, as amended ('''' Listing Regulations''''), please find attached herewith the Annual Report of the Company for the .... 路 08 Sept 2026
- Notice of 20th AGM 路 08 Sept 2026
